journal cover

ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration

bioRxiv

Dec 19, 2019

Katheryn A.Q. CousinsJeffrey S. Phillips

Abstract

Under the ATN framework, cerebrospinal fluid analytes provide evidence of the presence or absence of Alzheimer’s disease pathological hallmarks: amyloid plaques (A), phosphorylated tau (T), and accompanying neurodegeneration (N). Still, differences in cerebrospinal fluid levels across a...read more

Mentioned in this Paper

ATN-2
Analysis
Plaque (Lesion)
Cohort
Tau Proteins
Pathology
Alzheimer's Disease
Gene Mutant
Nerve Degeneration
Phosphorylation
6
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Phosphoproteomics (Preprints)

Phosphoproteomics refers to the identification and quantification of phosphorylated proteins in the proteome. This approach provides a high-throughput method of examining the state of intracellular phosphorylation. Here are the latest preprints on phosphoproteomics.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

Frontotemporal Dementia

Frontotemporal dementia (FTD) refers to disorders caused by progressive neuronal loss in the frontal and temporal lobes of the brain. Here is the latest research on FTD and FTD-associated disorders.

Tauopathies

Tauopathies are neurodegenerative disorders caused due to misfolding and aggregation of the tau protein in neurofibrillary tangles in the brain. Discover the latest research on tauopathies here.

Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

BioRxiv Preprints

BioRxiv is the preprint server for biology, operated by Cold Spring Harbor Laboratory. Here are the latest biology preprint articles from bioRxiv.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on the underlying role of Tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's.

Alzheimer's Disease: Genes&Microglia (Preprints)

Genes and microglia are associated with the risk of developing and the progression of conditions such as Alzheimer's Disease (AD). Here are the latest preprints pertaining to this disease.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Glymphatics

The glymphatic system is a CSF-mediated waste clearance pathway that is formed by astroglial cells. The removal of potentially harmful substances such as amyloid protein is important to prevent toxic levels accumulate in the brain. Discover the latest research on glymphatics here.

Corticobasal Degeneration

Corticobasal Degeneration (CBD)is a rare, neurodegenerative disease of the cerebral cortex and the basal ganglia, characterized by movement disorders. Discover the latest research on CBD here.

Frontotemporal Lobar Degeneration

Frontotemporal lobar degeneration or frontotemporal dementia refers to a group of uncommon disorders that occur as a result of progressive nerve cell loss in the frontal and temporal lobes of the brain. Here is the latest research.

Related Papers

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

Alzheimer's & Dementia : Diagnosis, Assessment & Disease MonitoringMarch 20, 2018
Jana JanssensPeter P De Deyn
© 2020 Meta ULC. All rights reserved

ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration

bioRxiv

Dec 19, 2019

Katheryn A.Q. CousinsJeffrey S. Phillips

PMID: 990881441

DOI: 10.1101/2019.12.18.881441

Abstract

Under the ATN framework, cerebrospinal fluid analytes provide evidence of the presence or absence of Alzheimer’s disease pathological hallmarks: amyloid plaques (A), phosphorylated tau (T), and accompanying neurodegeneration (N). Still, differences in cerebrospinal fluid levels across a...read more

Mentioned in this Paper

ATN-2
Analysis
Plaque (Lesion)
Cohort
Tau Proteins
Pathology
Alzheimer's Disease
Gene Mutant
Nerve Degeneration
Phosphorylation
6

Similar Papers Found In These Feeds

Phosphoproteomics (Preprints)

Phosphoproteomics refers to the identification and quantification of phosphorylated proteins in the proteome. This approach provides a high-throughput method of examining the state of intracellular phosphorylation. Here are the latest preprints on phosphoproteomics.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

Related Papers

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

Alzheimer's & Dementia : Diagnosis, Assessment & Disease MonitoringMarch 20, 2018
Jana JanssensPeter P De Deyn
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/atn-status-in-amnestic-and-non-amnestic/990881441